The revelation of encouraging preclinical data caused Portage Biotech Inc.’s (NASDAQ: PRTG) stock price to spike higher. PRTG shares were trading at $12.90 as of
The stock value of Portage Biotech Inc. (NASDAQ: PRTG) skyrocketed following the release of promising preclinical results. PRTG stock was selling at $9.64 as of
Shares of Portage Biotech Inc. (NASDAQ: PRTG) are experiencing upward momentum, rising 4.31% to $4.60 during the pre-market session. This increase follows the announcement of
Following a significant strategic decision, the stock value of Portage Biotech Inc. (NASDAQ: PRTG) has increased significantly, with shares rising by 124.62% to $7.30. This
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.